# Predictive Capacity of COVID-19 Test Positivity Rate

^{1}

^{2}

^{*}

## Abstract

**:**

## 1. Introduction

## 2. Material and Methods

#### 2.1. The Statistical Method Applied

#### 2.2. Estimation of the Model Order and the $\lambda $ Parameter

## 3. Results

#### 3.1. Analysis of the TPR Predictive Capacity

#### 3.2. Forecasting Hospital Overload

## 4. Discussion

- (1)
- The data on the antigen tests administrated are provided;
- (2)
- The time series of new positive cases should include the daily number of new positives tested using only antigen tests;
- (3)
- The TPR should reach a peak before the hospitalized and ICU patients reach theirs.

- Growth rate: positives daily variation;
- Incidence: fraction of COVID-19 positives per 100,000 individuals;
- The reproduction number ${R}_{t}$: number of secondary infections generated from a case at time t.

## 5. Conclusions

## Author Contributions

## Funding

## Institutional Review Board Statement

## Informed Consent Statement

## Data Availability Statement

## Acknowledgments

## Conflicts of Interest

## References

- Russell, T.W.; Golding, N.; Hellewell, J.; Abbott, S.; Wright, L.; Pearson, C.A.; van Zandvoort, K.; Jarvis, C.I.; Gibbs, H.; Liu, Y.; et al. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC Med.
**2020**, 18, 332. [Google Scholar] [CrossRef] - Fenga, L. CoViD-19: An automatic, semiparametric estimation method for the population infected in Italy. PeerJ
**2021**, 9, e10819. [Google Scholar] [CrossRef] [PubMed] - Gaspari, M. A novel epidemiological model for COVID-19. medRxiv
**2020**. [Google Scholar] [CrossRef] - Jewell, N.P.; Lewnard, J.A.; Jewell, B.L. Predictive mathematical models of the COVID-19 pandemic: Underlying principles and value of projections. JAMA
**2020**, 323, 1893–1894. [Google Scholar] [CrossRef] [PubMed] - Li, Q.; Feng, W.; Quan, Y.H. Trend and forecasting of the COVID-19 outbreak in China. J. Infect.
**2020**, 80, 469–496. [Google Scholar] - Sarkar, K.; Khajanchi, S.; Nieto, J.J. Modeling and forecasting the COVID-19 pandemic in India. Chaos Solitons Fractals
**2020**, 139, 110049. [Google Scholar] [CrossRef] [PubMed] - Shinde, G.R.; Kalamkar, A.B.; Mahalle, P.N.; Dey, N.; Chaki, J.; Hassanien, A.E. Forecasting models for coronavirus disease (COVID-19): A survey of the state-of-the-art. SN Comput. Sci.
**2020**, 1, 1–15. [Google Scholar] [CrossRef] - Bertozzi, A.L.; Franco, E.; Mohler, G.; Short, M.B.; Sledge, D. The challenges of modeling and forecasting the spread of COVID-19. Proc. Natl. Acad. Sci. USA
**2020**, 117, 16732–16738. [Google Scholar] [CrossRef] - Ioannidis, J.P.; Cripps, S.; Tanner, M.A. Forecasting for COVID-19 has failed. Int. J. Forecast.
**2020**. [Google Scholar] [CrossRef] - Fenga, L. Forecasting the CoViD-19 diffusion in Italy and the related occupancy of Intensive Care Units. J. Probab. Stat.
**2021**. [Google Scholar] [CrossRef] - Fenga, L.; Del Castello, C. CoViD19 Meta heuristic optimization based forecast method on time dependent bootstrapped data. medRxiv
**2020**. [Google Scholar] [CrossRef][Green Version] - Hasell, J.; Mathieu, E.; Beltekian, D.; Macdonald, B.; Giattino, C.; Ortiz-Ospina, E.; Roser, M.; Ritchie, H. A cross-country database of COVID-19 testing. Sci. Data
**2020**, 7, 1–7. [Google Scholar] [CrossRef] [PubMed] - Ellis, P. Test Positivity Rates and Actual Incidence and Growth of Diseases. Available online: http://freerangestats.info/blog/2020/05/09/covid-population-incidence (accessed on 11 February 2021).
- Chiu, W.A.; Ndeffo-Mbah, M.L. Using test positivity and reported case rates to estimate state-level COVID-19 prevalence in the United States. medRxiv
**2020**. [Google Scholar] [CrossRef] - Omori, R.; Mizumoto, K.; Chowell, G. Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate. Int. J. Infect. Dis.
**2020**, 94, 116–118. [Google Scholar] [CrossRef] - Gaspari, M. COVID-19 Test Positivity Rate as a marker for hospital overload. medRxiv
**2021**. [Google Scholar] [CrossRef] - Box, G.E.; Jenkins, G.M.; Reinsel, G.C.; Ljung, G.M. Time Series Analysis: Forecasting and Control; John Wiley & Sons: Hoboken, NJ, USA, 2015. [Google Scholar]
- Funke, M. Time-series forecasting of the German unemployment rate. J. Forecast.
**1992**, 11, 111–125. [Google Scholar] [CrossRef] - Dritsaki, C. Forecast of SARIMA models: An application to unemployment rates of Greece. Am. J. Appl. Math. Stat.
**2016**, 4, 136–148. [Google Scholar] - Luo, X.; Niu, L.; Zhang, S. An algorithm for traffic flow prediction based on improved SARIMA and GA. KSCE J. Civ. Eng.
**2018**, 22, 4107–4115. [Google Scholar] [CrossRef] - Mombeni, H.A.; Rezaei, S.; Nadarajah, S.; Emami, M. Estimation of water demand in Iran based on SARIMA models. Environ. Model. Assess.
**2013**, 18, 559–565. [Google Scholar] [CrossRef] - Nobre, F.F.; Monteiro, A.B.S.; Telles, P.R.; Williamson, G.D. Dynamic linear model and SARIMA: A comparison of their forecasting performance in epidemiology. Stat. Med.
**2001**, 20, 3051–3069. [Google Scholar] [CrossRef] - Chen, Y.; Leng, K.; Lu, Y.; Wen, L.; Qi, Y.; Gao, W.; Chen, H.; Bai, L.; An, X.; Sun, B.; et al. Epidemiological features and time-series analysis of influenza incidence in urban and rural areas of Shenyang, China, 2010–2018. Epidemiol. Infect.
**2020**, 148, e29. [Google Scholar] [CrossRef] [PubMed][Green Version] - Liu, H.; Li, C.; Shao, Y.; Zhang, X.; Zhai, Z.; Wang, X.; Qi, X.; Wang, J.; Hao, Y.; Wu, Q.; et al. Forecast of the trend in incidence of acute hemorrhagic conjunctivitis in China from 2011–2019 using the Seasonal Autoregressive Integrated Moving Average (SARIMA) and Exponential Smoothing (ETS) models. J. Infect. Public Health
**2020**, 13, 287–294. [Google Scholar] [CrossRef] - Boyce, R.M.; Reyes, R.; Matte, M.; Ntaro, M.; Mulogo, E.; Lin, F.C.; Siedner, M.J. Practical implications of the non-linear relationship between the test positivity rate and malaria incidence. PLoS ONE
**2016**, 11, e0152410. [Google Scholar] - World Health Organization. Considerations for Implementing and Adjusting Public Health and Social Measures in the Context of COVID-19: Interim Guidance, 4 November 2020; Technical Report; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
- Turcato, G.; Zaboli, A.; Pfeifer, N.; Ciccariello, L.; Sibilio, S.; Tezza, G.; Ausserhofer, D. Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: A preliminary report. J. Infect.
**2020**, 82, e14–e16. [Google Scholar] [CrossRef] [PubMed] - Box, G.E.; Cox, D.R. An analysis of transformations. J. R. Stat. Soc. Ser. B Methodol.
**1964**, 26, 211–243. [Google Scholar] [CrossRef] - Sakia, R.M. The Box-Cox transformation technique: A review. J. R. Stat. Soc. Ser. D Stat.
**1992**, 41, 169–178. [Google Scholar] [CrossRef] - Hulten, C.R.; Wykoff, F.C. The estimation of economic depreciation using vintage asset prices: An application of the Box-Cox power transformation. J. Econom.
**1981**, 15, 367–396. [Google Scholar] [CrossRef] - Kim, S.; Chen, M.H.; Ibrahim, J.G.; Shah, A.K.; Lin, J. Bayesian inference for multivariate meta-analysis Box–Cox transformation models for individual patient data with applications to evaluation of cholesterol-lowering drugs. Stat. Med.
**2013**, 32, 3972–3990. [Google Scholar] [CrossRef] - Akaike, H. A new look at the statistical model identification. IEEE Trans. Autom. Control
**1974**, 19, 716–723. [Google Scholar] [CrossRef] - Bozdogan, H. Model selection and Akaike’s information criterion (AIC): The general theory and its analytical extensions. Psychometrika
**1987**, 52, 345–370. [Google Scholar] [CrossRef] - Hu, S. Akaike Information Criterion; Center for Research in Scientific Computation, North Carolina State University: Raleigh, NC, USA, 2007. [Google Scholar]
- Ozaki, T. On the order determination of ARIMA models. J. R. Stat. Soc. Ser. C Appl. Stat.
**1977**, 26, 290–301. [Google Scholar] [CrossRef] - Akaike, H. Modern development of statistical methods. In Trends and Progress in System Identification; Elsevier: Amsterdam, The Netherlands, 1981; pp. 169–184. [Google Scholar]
- Ascoli, C.A. Could mutations of SARS-CoV-2 suppress diagnostic detection? Nat. Biotechnol.
**2021**, 39, 274–275. [Google Scholar] [CrossRef] [PubMed] - García-Basteiro, A.L.; Chaccour, C.; Guinovart, C.; Llupià, A.; Brew, J.; Trilla, A.; Plasencia, A. Monitoring the COVID-19 epidemic in the context of widespread local transmission. Lancet Respir. Med.
**2020**, 8, 440–442. [Google Scholar] [CrossRef] - Tong, A.; Sorrell, T.C.; Black, A.J.; Caillaud, C.; Chrzanowski, W.; Li, E.; Martinez-Martin, D.; McEwan, A.; Wang, R.; Motion, A.; et al. Research priorities for COVID-19 sensor technology. Nat. Biotechnol.
**2021**, 39, 144–147. [Google Scholar] [CrossRef] [PubMed] - Cappe, O.; Moulines, E.; Ryden, T. Inference in Hidden Markov Models; Springer Science & Business Media: New York, NY, USA, 2006. [Google Scholar]
- Beynon, M.; Curry, B.; Morgan, P. The Dempster—Shafer theory of evidence: An alternative approach to multicriteria decision modelling. Omega
**2000**, 28, 37–50. [Google Scholar] [CrossRef]

**Figure 2.**The TPR index (orange dotted lines) and hospitalized patients time series of Toscana, Veneto, Piemonte, and Alto Adige.

**Figure 3.**Forecasting hospitalized patients growth in 5 different scenarios for regions: Toscana, Alto Adige, Piemonte, and Veneto (also including a fast lowering example). The orange dotted lines represent the TPR index.

**Figure 4.**Developing point-of-care (instant) screening tests for COVID-19: data collection, sensors technology, TPR calculation, and information flows.

**Table 1.**This table presents the results of the regression models with Seasonal Auto Regressive Moving Average (SARIMA) errors concerning patients admitted in hospitals and intensive care units for Toscana, Veneto, Alto Adige, and Piemonte regions. The columns Days and Beds indicate the TPR predictive capacity in days (with the associated t-value) and the estimated variation of beds in both hospitals and Intensive Care Units (ICUs).

Region | Days | Hospitalized t-Value | Beds | Days | ICU t-Value | Beds |
---|---|---|---|---|---|---|

Toscana | 12 | 2.34 | 54 | 12 | 2.05 | 9 |

Piemonte | 12 | 3.82 | 86 | 12 | 2.03 | 36 |

Veneto | 13 | 2.07 | 82 | 13 | 2.52 | 12 |

Alto Adige | 12 | 1.92 | 30 | 12 | 5.60 | 8 |

**Table 2.**This table presents the detailed results of the experiment presented in Section 3.1, for studying the SARIMA lagged correlation between the TPR time series and those of patients admitted in hospitals and ICUs. The last two columns Days and Beds indicate the TPR predictive capacity in days and the number of additional beds in hospital or ICU after 12 days for each TPR unit.

Toscana | ||||||||||

SARIMA(2, 1, 0)(1, 0, 1) Box Cox trans: $\lambda $ = 1.2 ${\beta}_{t-value}$ = 2.34 | ||||||||||

${\varphi}_{1}$ | ${\varphi}_{2}$ | ${\Phi}_{1}$ | ${\Theta}_{1}$ | $\beta $ | $Days$ | $Beds$ | ||||

Hosp: | 0.45 | 0.18 | 0.91 | −0.69 | 100.61 | 12 | 54 | |||

s.e. | 0.08 | 0.09 | 0.063 | 0.13 | 43.00 | |||||

SARIMA(2, 1, 0)(0, 0, 1) Box Cox trans: $\lambda $ = 1.2 ${\beta}_{t-value}$ = 2.05 | ||||||||||

${\varphi}_{1}$ | ${\varphi}_{2}$ | ${\Theta}_{1}$ | $\beta $ | $Days$ | $Beds$ | |||||

ICU: | 0.12 | 0.29 | 0.15 | 10.18 | 12 | 9 | ||||

s.e. | 0.09 | 0.09 | 0.09 | 4.98 | ||||||

Veneto | ||||||||||

SARIMA(2,1,1)(1,0,1) Box Cox trans: $\lambda $= 1.4 ${\beta}_{t-value}$=2.07 | ||||||||||

${\varphi}_{1}$ | ${\varphi}_{2}$ | ${\theta}_{1}$ | ${\Phi}_{1}$ | ${\Theta}_{1}$ | $\beta $ | $Days$ | $Beds$ | |||

Hosp: | 0.73 | 0.21 | −0.76 | 0.77 | −0.60 | 341.70 | 13 | 82 | ||

s.e. | 0.11 | 0.09 | 0.08 | 0.15 | 0.19 | 164.82 | ||||

SARIMA(0,1,1)(0,1,1) Box Cox trans: $\lambda $ = 1.34 ${\beta}_{t-value}$ = 2.52 | ||||||||||

${\theta}_{1}$ | ${\Theta}_{1}$ | $\beta $ | $Days$ | $Beds$ | ||||||

ICU: | 0.06 | −0.67 | 20.72 | 13 | 12 | |||||

s.e. | 0.09 | 0.09 | 8.22 | |||||||

Alto Adige | ||||||||||

SARIMA(3, 1, 0)(0, 1, 1) Box Cox transf: $\lambda $ = 1.69 ${\beta}_{t-value}$ = 1.92 | ||||||||||

${\varphi}_{1}$ | ${\varphi}_{2}$ | ${\varphi}_{3}$ | ${\Theta}_{1}$ | $\beta $ | $Days$ | $Beds$ | ||||

Hosp: | 0.27 | −0.25 | 0.36 | −1.00 | 182.07 | 12 | 30 | |||

s.e. | 0.08 | 0.08 | 0.09 | 0.07 | 94.66 | |||||

SARIMA(0, 0, 3)(0, 1, 2)) Box Cox transf: $\lambda $ = 1.98 ${\beta}_{t-value}$ = 5.60 | ||||||||||

${\theta}_{1}$ | ${\theta}_{2}$ | ${\theta}_{3}$ | ${\Theta}_{1}$ | ${\Theta}_{2}$ | $\beta $ | $Days$ | $Beds$ | |||

ICU: | 1.06 | 1.04 | 0.63 | −0.58 | −0.30 | 27.12 | 12 | 8 | ||

s.e. | 0.06 | 0.07 | 0.06 | 0.13 | 0.10 | 4.84 | ||||

Piemonte | ||||||||||

SARIMA(10,1,1)(1,1,1) Box Cox: $\lambda $ = 3 ${\beta}_{t-value}$ = 3.82 | ||||||||||

${\varphi}_{3}$ | ${\varphi}_{5}$ | ${\varphi}_{6}$ | ${\varphi}_{10}$ | ${\Theta}_{1}$ | ${\Phi}_{1}$ | ${\theta}_{1}$ | $\beta $ | $Days$ | $Beds$ | |

Hosp: | 0.22 | 0.11 | 0.31 | 0.19 | 0.16 | 0.21 | −1.0 | 211,187.31 | 12 | 86 |

s.e. | 0.08 | 0.07 | 0.08 | 0.07 | 0.09 | 0.09 | 0.05 | 55,285.44 | ||

SARIMA(3,1,0)(0,1,1) Box Cox: $\lambda $=1.2 ${\beta}_{t-value}$=2.03 | ||||||||||

${\varphi}_{1}$ | ${\varphi}_{2}$ | ${\varphi}_{3}$ | ${\theta}_{1}$ | $\beta $ | $Days$ | $Beds$ | ||||

ICU: | 0.38 | 0.36 | 0.17 | −0.83 | 60.33 | 12 | 36 | |||

s.e. | 0.08 | 0.08 | 0.08 | 0.08 | 29.74 |

Region | Situation | Training Set | Obs | Test Set | Obs |
---|---|---|---|---|---|

Toscana | fast growing | 02/09/20–10/31/20 | 60 | 01/11/20–15/11/20 | 15 |

Piemonte | red zone start | 02/09/20–06/11/20 | 66 | 07/11/20–22/11/20 | 15 |

Veneto | slow growing | 02/09/20–09/12/20 | 99 | 13/12/20–28/12/20 | 15 |

Veneto | fast lowering | 02/09/20–29/12/20 | 136 | 15/01/21–30/01/21 | 15 |

Alto Adige | fast growing | 02/09/20–04/11/20 | 64 | 05/11/20–20/11/20 | 15 |

**Table 4.**Pure predictive capacity in days of different COVID-19 indicators with respect to hospitalization.

Metrics | What It Represents | Days |
---|---|---|

TPR | Number of active cases in a region also | 15 |

embodying the unknown portion of asymptomatic | ||

Growth rate | Variation of detected positive cases in a region | 4 |

Incidence | Number of known cases in a region | 4 |

${R}_{t}$ index | Variation of the infections dynamics in a region | 4 |

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

## Share and Cite

**MDPI and ACS Style**

Fenga, L.; Gaspari, M.
Predictive Capacity of COVID-19 Test Positivity Rate. *Sensors* **2021**, *21*, 2435.
https://doi.org/10.3390/s21072435

**AMA Style**

Fenga L, Gaspari M.
Predictive Capacity of COVID-19 Test Positivity Rate. *Sensors*. 2021; 21(7):2435.
https://doi.org/10.3390/s21072435

**Chicago/Turabian Style**

Fenga, Livio, and Mauro Gaspari.
2021. "Predictive Capacity of COVID-19 Test Positivity Rate" *Sensors* 21, no. 7: 2435.
https://doi.org/10.3390/s21072435